These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Acute fulminant myocarditis in a young man of 19]. Melis G; Pérez-Villa F; Paré JC; Riverola A; Navarro-López F Rev Esp Cardiol; 1991 Mar; 44(3):213-5. PubMed ID: 2047553 [TBL] [Abstract][Full Text] [Related]
25. Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock. Mody KP; Takayama H; Landes E; Yuzefpolskaya M; Colombo PC; Naka Y; Jorde UP; Uriel N J Cardiovasc Transl Res; 2014 Mar; 7(2):156-64. PubMed ID: 24420915 [TBL] [Abstract][Full Text] [Related]
26. Postural hypotension as the initial presentation of fulminant right ventricular myocarditis. Ho CH; Wu YC; Lin YY; Hsu CW; Tsai SH Am J Emerg Med; 2010 Jul; 28(6):708-10. PubMed ID: 20637387 [TBL] [Abstract][Full Text] [Related]
27. Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis. Gaudriot B; Mansour A; Thibault V; Lederlin M; Cauchois A; Lelong B; Ross JT; Leurent G; Tadié JM; Revest M; Verhoye JP; Flecher E; Nesseler N ESC Heart Fail; 2021 Aug; 8(4):2625-2630. PubMed ID: 33934560 [TBL] [Abstract][Full Text] [Related]
28. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Asaumi Y; Yasuda S; Morii I; Kakuchi H; Otsuka Y; Kawamura A; Sasako Y; Nakatani T; Nonogi H; Miyazaki S Eur Heart J; 2005 Oct; 26(20):2185-92. PubMed ID: 16014643 [TBL] [Abstract][Full Text] [Related]
34. When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature. Hékimian G; Jovanovic T; Bréchot N; Lebreton G; Leprince P; Trouillet JL; Schmidt M; Nieszkowska A; Besset S; Chastre J; Combes A; Luyt CE J Crit Care; 2018 Oct; 47():61-64. PubMed ID: 29929152 [TBL] [Abstract][Full Text] [Related]
35. [Acute viral myocarditis with transient concentric pseudohypertrophy of the left ventricle complicated by cardiogenic shock]. Piancastelli M; Grilli M; Ravaioli ML; Preziosi S; Bellanti G; Zabberoni W G Ital Cardiol; 1993 Dec; 23(12):1223-8. PubMed ID: 8174874 [TBL] [Abstract][Full Text] [Related]
38. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis. Du H; Du Z; Wang L; Wang H; Jia M; Zhang C; Liu Y; Zhang C; Zhang Y; Zhang R; Zhang S; Zhang N; Ma Z; Chen C; Liu W; Zeng H; Gao GF; Hou X; Bi Y J Genet Genomics; 2024 Jun; 51(6):608-616. PubMed ID: 38447818 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and Clinical Implications of COVID-19 Myocarditis. Chimenti C; Magnocavallo M; Ballatore F; Bernardini F; Alfarano M; Della Rocca DG; Severino P; Lavalle C; Francesco F; Frustaci A Card Electrophysiol Clin; 2022 Mar; 14(1):53-62. PubMed ID: 35221085 [TBL] [Abstract][Full Text] [Related]
40. Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report. Ebert D; Mungard N; Mensch A; Homeister L; Willsch J; Ibe R; Baust H; Stiller M; Rebelo A; Ukkat J; Rigopoulos AG; Weber E; Bucher M; Noutsias M BMC Cardiovasc Disord; 2021 Nov; 21(1):528. PubMed ID: 34743690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]